Joseph Lord

Search results

• 2024

  Artificial Intelligence Technologies for Assessing Skin Lesions for Referral on the Urgent Suspected Cancer Pathway to Detect Benign Lesions and Reduce Secondary Care Specialist Appointments: Early Value Assessment

  Walton, M. J., Llewellyn, A., Uphoff, N., Lord, J., Harden, M., Hodgson, R. & Simmonds, M. C., 28 Aug 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Bimekizumab for treating moderate to severe hidradenitis suppurativa

  Lord, J., Perry, M. C., Wade, R., Harden, M., Walton, M. J. & Simmonds, M. C., 7 Oct 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Dapagliflozin for the treatment of adults with chronic kidney disease (Review of TA775): Cost comparison evaluation process

  Perry, M. C., Llewellyn, A., Lord, J., Harden, M., Kunst, N. & Nevitt, S. J., 5 Sept 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia

  Deng, J., Corbett, M. S., Uphoff, N., Lord, J., Fulbright, H., Griffin, S., Rothery, C. & Hodgson, R., 2 Aug 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer

  Corbett, M. S., Deng, J., Uphoff, N., Walton, M. J., Lord, J., Fulbright, H. A., Dwan, K. & Hodgson, R., 7 Feb 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report

• Selective internal radiation therapy with QuiremSpheres for treating unresectable advanced hepatocellular carcinoma (Partial review of TA688)

  Uphoff, N., Lord, J., Anwer, S., Harden, M., Baker, M., Walton, M. J. & Nevitt, S. J., 3 Jul 2024, National Institute for Health and Care Excellence.

  Research output: Book/Report › Commissioned report